Antimicrobial peptides (AMPs) have garnered significant attention in recent years due to their potent ability to combat a wide variety of pathogenic microorganisms.
These short chains of amino acids play a crucial role in the innate immune response, acting as the first line of defense against harmful bacteria, fungi, and viruses.
As the threat of multidrug-resistant organisms rises globally, the search for alternative therapeutic agents has intensified. Continue reading